Cost-Effectiveness of Mirabegron Compared with Tolterodine ER 4mg for the Treatment of Patients with Overactive Bladder in the United Kingdom- Results from a Trial-Based Model
Nov 1, 2013, 00:00 AM
10.1016/j.jval.2013.08.1886
https://www.valueinhealthjournal.com/article/S1098-3015(13)03791-1/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1719
First Page :
A633
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)03791-1&doi=10.1016/j.jval.2013.08.1886